Latham Advises Pet Meds Maker Putney In $200M Dechra Sale
Latham & Watkins LLP guided pet generic drugmaker Putney in a $200 million cash sale to Dechra Holdings US Inc., the companies said on Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article